News Overview

With effect from 12 March 2022

Equity indices traded higher with decent gains in early trade. The Nifty traded near the 16,700 mark. Banking and financial stocks saw buying demand while auto and FMCG shares came under selling pressure. At 9:20 IST, the barometer index, the S&P BSE Sensex, rose 169.62 points or 0.31% at 55,719.15. The Nifty 50 index gained 41.65 points or 0.25% at 16,672.90. In the broader market, […]

Indias industrial production index rose 1.3 percent year-on-year in January, preliminary data from the statistics ministry showed Friday. In the same month last year, output shrank 0.6 percent. The December growth was revised to 0.7 percent from 0.4 percent. In January, manufacturing grew 1.1 percent year-on-year, mining production rose 2.8 percent and electricity output increased 0.9 percent. In the April to January period, industrial production […]

Lupin said that it has received approval from the United States Food and Drug Administration (FDA) for Vigabatrin for oral solution USP.

In case, the Board decides to consider and declare the 2nd interim dividend, the record date for payment of Dividend would be March 29, 2022.

Zydus Lifesciences has received final approval from the USFDA to market Colestipol Hydrochloride Tablets in the strength of 1mg (US RLD: Colestid). Colestipol hydrochloride tablets are indicated as adjunctive therapy to diet for the reduction of elevated serum total and LDL-C in patients with primary hypercholesterolemia (elevated LDL-C) who do not respond adequately to diet. Colestipol Hydrochloride is a highly complex macro molecule drug substance […]

Through this MoU, BSE and Onsurity will plan and undertake seminars, public relations events, press releases, testimonials, demonstrations.

NHPC had already paid Rs249.44 crore to Government of India during the current fiscal 2021-22 on account of final dividend for the financial year 2020-21.

Back in 2013, India was identified among the “Fragile Fiveâ€; economies most vulnerable to a post GFC taper. At that time the rupee and Sensex had crashed. This time, the Indian economy looks a lot stronger.

Zydus Lifesciences received the final approval from the US-based drug regulator, the United States Food & Drug Administration (USFDA) to market Colestipol Hydrochloride tablets (in the strength of 1mg).